Effects of Respiratory Training on Respiratory and Functional Performance in Patients With Stroke
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Chung-Hao Chuang, PhD study.
- Phone Number: +886-95253993
- Email: chuang5959@yahoo.com.tw
Study Contact Backup
- Name: Chun-Hou Wang, Professor.
- Phone Number: 11015 +886-4-24730022
- Email: wangcsmu@gmail.com
Study Locations
-
-
-
Taichung, Taiwan, 42010
- Chung Shan Medical University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- first episode of unilateral stroke.
- the definition of stroke was according to the World Health Organization (WHO) criteria (Hatano 1976), confirmed by computerized tomography (CT) or magnetic resonance imaging (MRI).
- older than 20 years.
- had maximum inspiratory pressure (MIP) values lower than 90% of those predicted and adjusted for age and sex.
- facial palsy, which could not prevent proper labial occlusion.
- ability to understand and follow simple verbal instructions.
- no receptive aphasia.
- not undergone thoracic or abdominal surgery.
Exclusion Criteria:
- unable to perform the tests.
- impaired level of consciousness and evidence of gross cognitive impairment.
- excluded patients with comorbidities of respiratory system disease (e.g. chronic obstructive pulmonary disease, asthma, cystic fibrosis), or other diseases leading to the impairment of respiratory muscle (e.g. myasthenia gravis).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: RT (respiratory training) group
Besides traditional rehabilitation therapy, subjects also receive 12-week respiratory training.
|
breathing exercise.
|
|
Sham Comparator: Control group
Besides traditional rehabilitation therapy, subjects receive 12-week sham training unrelated to respiratory function.
|
range of motion (ROM) exercise, stretching exercise or positioning exercise.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diaphragm Thickness.
Time Frame: change from baseline diaphragm thickness at 12, 16, 24, 36 weeks.
|
In this study, the mid axillary lines between ribs 8 and 9 on both sides will be checked in a standing posture, then the chest wall is perpendicularly illuminated by a curved array 2-5 MHz transducer (Siemens Sololine G40) in an upright sitting position to observe the region between rib 8 and rib 9 in 2D images.
The diaphragm thickness is measured as the distance between two parallel lines that appear bright in the middle of the pleura and in the middle peritoneum.
|
change from baseline diaphragm thickness at 12, 16, 24, 36 weeks.
|
|
Incidence of Pneumonia.
Time Frame: change from baseline incidence of pneumonia at 12, 16, 24, 36 weeks.
|
This study will observe the incidence of pneumonia of two groups in the 36-week research course.
|
change from baseline incidence of pneumonia at 12, 16, 24, 36 weeks.
|
|
Brunnstrom's motor recovery stages.
Time Frame: change from baseline Brunnstrom's stages at 12, 16, 24, 36 weeks.
|
The six sequential stages of motor recovery through which the hemiplegic upper and lower extremities progress used as a method for assessing recovery.
|
change from baseline Brunnstrom's stages at 12, 16, 24, 36 weeks.
|
|
Stroke Rehabilitation Assessment of Movement scale; STREAM.
Time Frame: change from baseline STREAM scores at 12, 16, 24, 36 weeks.
|
The STREAM scale is used to evaluate the recovery of voluntary movement and basic mobility following stroke.
The scale consists of 30 items or test movements that are equally distributed among 3 subscales: upper-limb movements, lower-limb movements, and basic mobility items.
|
change from baseline STREAM scores at 12, 16, 24, 36 weeks.
|
|
Stroke-Specific Quality of Life scale; SS-QOL.
Time Frame: change from baseline SS-QOL scores at 12, 16, 24, 36 weeks.
|
The SS-QOL scale is a patient-centered outcome measure intended to provide an assessment of health-related quality of life specific to patients with stroke.
It consists of twelve commonly affected domains (energy, family roles, language, mobility, mood, personality, self-care, social roles, thinking, upper extremity functioning, vision, and work/productivity) and 49 items.
|
change from baseline SS-QOL scores at 12, 16, 24, 36 weeks.
|
|
Stroke Impact Scale; SIS 3.0.
Time Frame: change from baseline SIS 3.0 scores at 12, 16, 24, 36 weeks.
|
The SIS 3.0 is a stroke-specific, self-report, health status measure.
The scale includes 59 items and assesses 8 domains.
It was designed to assess multidimensional stroke outcomes, including strength, hand function, activities of daily living/instrumental activities of daily living (ADL/IADL), mobility, communication, emotion, memory and thinking, and participation.
|
change from baseline SIS 3.0 scores at 12, 16, 24, 36 weeks.
|
|
Twelve-Minute Walk Test.
Time Frame: change from baseline Twelve-Minute Walk Test scores at 12, 16, 24, 36 weeks.
|
The distance (in meters) that a subject can walk within twelve minutes is evaluated.
|
change from baseline Twelve-Minute Walk Test scores at 12, 16, 24, 36 weeks.
|
|
Forced Vital Capacity (FVC) in liters.
Time Frame: change from baseline FVC at 12, 16, 24, 36 weeks.
|
Resting spirometry of FVC will be performed on a spirometer.
|
change from baseline FVC at 12, 16, 24, 36 weeks.
|
|
Vital Capacity (VC) in liters.
Time Frame: change from baseline VC at 12, 16, 24, 36 weeks.
|
Resting spirometry of VC will be performed on a spirometer.
|
change from baseline VC at 12, 16, 24, 36 weeks.
|
|
Forced Expiratory Volume at 1 second (FEV1) in liters.
Time Frame: change from baseline FEV1 at 12, 16, 24, 36 weeks.
|
Resting spirometry of FEV1 will be performed on a spirometer.
|
change from baseline FEV1 at 12, 16, 24, 36 weeks.
|
|
Ratio of FEV1 to FVC (FEV1/FVC).
Time Frame: change from baseline FEV1/FVC ratio at 12, 16, 24, 36 weeks.
|
Resting spirometry of FEV1/FVC ratio will be performed on a spirometer.
|
change from baseline FEV1/FVC ratio at 12, 16, 24, 36 weeks.
|
|
Forced Expiratory Flow rate 25-75% (FEF 25-75%) in liters per minute.
Time Frame: change from baseline FEF 25-75% at 12, 16, 24, 36 weeks.
|
Resting spirometry of FEF 25-75% will be performed on a spirometer.
|
change from baseline FEF 25-75% at 12, 16, 24, 36 weeks.
|
|
Peak Expiratory Flow Rate (PEFR) in liters per minute.
Time Frame: change from baseline PEFR at 12, 16, 24, 36 weeks.
|
Resting spirometry of PEFR will be performed on a spirometer.
|
change from baseline PEFR at 12, 16, 24, 36 weeks.
|
|
Maximum Inspiratory Pressure (PImax) in centimeters of water pressure (cmH2O).
Time Frame: change from baseline PImax at 12, 16, 24, 36 weeks.
|
Resting spirometry of PImax will be performed on a spirometer.
|
change from baseline PImax at 12, 16, 24, 36 weeks.
|
|
Maximum Expiratory Pressures (PEmax) in centimeters of water pressure (cmH2O).
Time Frame: change from baseline PEmax at 12, 16, 24, 36 weeks.
|
Resting spirometry of PEmax will be performed on a spirometer.
|
change from baseline PEmax at 12, 16, 24, 36 weeks.
|
|
Maximum Voluntary Ventilation (MVV) in liters per minute.
Time Frame: change from baseline MVV at 12, 16, 24, 36 weeks.
|
Resting spirometry of MVV will be performed on a spirometer.
|
change from baseline MVV at 12, 16, 24, 36 weeks.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Chung-Hao Chuang, PhD study., Chung Shan Medical University
Publications and helpful links
General Publications
- Duncan PW, Bode RK, Min Lai S, Perera S; Glycine Antagonist in Neuroprotection Americans Investigators. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Arch Phys Med Rehabil. 2003 Jul;84(7):950-63. doi: 10.1016/s0003-9993(03)00035-2.
- American College of Sports Medicine. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2009 Mar;41(3):687-708. doi: 10.1249/MSS.0b013e3181915670.
- Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011 Feb 1;123(4):e18-e209. doi: 10.1161/CIR.0b013e3182009701. Epub 2010 Dec 15. Erratum In: Circulation. 2011 Feb 15;123(6):e240. Circulation. 2011 Oct 18;124(16):e426.
- Ueki J, De Bruin PF, Pride NB. In vivo assessment of diaphragm contraction by ultrasound in normal subjects. Thorax. 1995 Nov;50(11):1157-61. doi: 10.1136/thx.50.11.1157.
- Duncan PW, Wallace D, Lai SM, Johnson D, Embretson S, Laster LJ. The stroke impact scale version 2.0. Evaluation of reliability, validity, and sensitivity to change. Stroke. 1999 Oct;30(10):2131-40. doi: 10.1161/01.str.30.10.2131.
- Daley K, Mayo N, Wood-Dauphinee S. Reliability of scores on the Stroke Rehabilitation Assessment of Movement (STREAM) measure. Phys Ther. 1999 Jan;79(1):8-19; quiz 20-3.
- Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, Creager MA, Culebras A, Eckel RH, Hart RG, Hinchey JA, Howard VJ, Jauch EC, Levine SR, Meschia JF, Moore WS, Nixon JV, Pearson TA; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research,; Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 Feb;42(2):517-84. doi: 10.1161/STR.0b013e3181fcb238. Epub 2010 Dec 2. Erratum In: Stroke. 2011 Feb;42(2):e26.
- Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J. 2005 Jul;26(1):153-61. doi: 10.1183/09031936.05.00034505. No abstract available.
- Messaggi-Sartor M, Guillen-Sola A, Depolo M, Duarte E, Rodriguez DA, Barrera MC, Barreiro E, Escalada F, Orozco-Levi M, Marco E. Inspiratory and expiratory muscle training in subacute stroke: A randomized clinical trial. Neurology. 2015 Aug 18;85(7):564-72. doi: 10.1212/WNL.0000000000001827. Epub 2015 Jul 15.
- Kulnik ST, Birring SS, Moxham J, Rafferty GF, Kalra L. Does respiratory muscle training improve cough flow in acute stroke? Pilot randomized controlled trial. Stroke. 2015 Feb;46(2):447-53. doi: 10.1161/STROKEAHA.114.007110. Epub 2014 Dec 11.
- Williams LS, Weinberger M, Harris LE, Clark DO, Biller J. Development of a stroke-specific quality of life scale. Stroke. 1999 Jul;30(7):1362-9. doi: 10.1161/01.str.30.7.1362.
- Kosak M, Smith T. Comparison of the 2-, 6-, and 12-minute walk tests in patients with stroke. J Rehabil Res Dev. 2005 Jan-Feb;42(1):103-7. doi: 10.1682/jrrd.2003.11.0171.
- Lanini B, Bianchi R, Romagnoli I, Coli C, Binazzi B, Gigliotti F, Pizzi A, Grippo A, Scano G. Chest wall kinematics in patients with hemiplegia. Am J Respir Crit Care Med. 2003 Jul 1;168(1):109-13. doi: 10.1164/rccm.200207-745OC. Epub 2003 Apr 24.
- Wang CH, Hsieh CL, Dai MH, Chen CH, Lai YF. Inter-rater reliability and validity of the stroke rehabilitation assessment of movement (stream) instrument. J Rehabil Med. 2002 Jan;34(1):20-4. doi: 10.1080/165019702317242668.
- Teixeira-Salmela LF, Parreira VF, Britto RR, Brant TC, Inacio EP, Alcantara TO, Carvalho IF. Respiratory pressures and thoracoabdominal motion in community-dwelling chronic stroke survivors. Arch Phys Med Rehabil. 2005 Oct;86(10):1974-8. doi: 10.1016/j.apmr.2005.03.035.
- WHO publishes definitive atlas on global heart disease and stroke epidemic. Indian J Med Sci. 2004 Sep;58(9):405-6. No abstract available.
- Pollock RD, Rafferty GF, Moxham J, Kalra L. Respiratory muscle strength and training in stroke and neurology: a systematic review. Int J Stroke. 2013 Feb;8(2):124-30. doi: 10.1111/j.1747-4949.2012.00811.x. Epub 2012 May 9.
- MCKELDEN SMITH. THE EFFECT OF HEMIPLEGIA ON THE DIAPHRAGM. Am Rev Respir Dis. 1964 Mar;89:450-2. doi: 10.1164/arrd.1964.89.3.450. No abstract available.
- Fluck DC. Chest movements in hemiplegia. Clin Sci. 1966 Dec;31(3):383-8. No abstract available.
- Korczyn AD, Leibowitz U, Bruderman I. Involvement of the diaphragm in hemiplegia. Neurology. 1969 Jan;19(1):97-100. doi: 10.1212/wnl.19.1.97. No abstract available.
- De Troyer A, Zegers De Beyl D, Thirion M. Function of the respiratory muscles in acute hemiplegia. Am Rev Respir Dis. 1981 Jun;123(6):631-2. doi: 10.1164/arrd.1981.123.6.631.
- Przedborski S, Brunko E, Hubert M, Mavroudakis N, de Beyl DZ. The effect of acute hemiplegia on intercostal muscle activity. Neurology. 1988 Dec;38(12):1882-4. doi: 10.1212/wnl.38.12.1882.
- Cohen E, Mier A, Heywood P, Murphy K, Boultbee J, Guz A. Diaphragmatic movement in hemiplegic patients measured by ultrasonography. Thorax. 1994 Sep;49(9):890-5. doi: 10.1136/thx.49.9.890.
- Xiao Y, Luo M, Wang J, Luo H. Inspiratory muscle training for the recovery of function after stroke. Cochrane Database Syst Rev. 2012 May 16;2012(5):CD009360. doi: 10.1002/14651858.CD009360.pub2.
- Efremidis G, Tsiamita M, Manolis A, Spiropoulos K. Accuracy of pulmonary function tests in predicted exercise capacity in COPD patients. Respir Med. 2005 May;99(5):609-14. doi: 10.1016/j.rmed.2004.08.018.
- Macko RF, Smith GV, Dobrovolny CL, Sorkin JD, Goldberg AP, Silver KH. Treadmill training improves fitness reserve in chronic stroke patients. Arch Phys Med Rehabil. 2001 Jul;82(7):879-84. doi: 10.1053/apmr.2001.23853.
- Foster JE, Maciewicz RA, Taberner J, Dieppe PA, Freemont AJ, Keen MC, Watt I, Waterton JC. Structural periodicity in human articular cartilage: comparison between magnetic resonance imaging and histological findings. Osteoarthritis Cartilage. 1999 Sep;7(5):480-5. doi: 10.1053/joca.1999.0243.
- Teresi JA, Holmes D. Should MDS data be used for research? Gerontologist. 1992 Apr;32(2):148-9. doi: 10.1093/geront/32.2.148. No abstract available.
- Derrickson J, Ciesla N, Simpson N, Imle PC. A comparison of two breathing exercise programs for patients with quadriplegia. Phys Ther. 1992 Nov;72(11):763-9. doi: 10.1093/ptj/72.11.763.
- Morris SL, Dodd KJ, Morris ME. Outcomes of progressive resistance strength training following stroke: a systematic review. Clin Rehabil. 2004 Feb;18(1):27-39. doi: 10.1191/0269215504cr699oa.
- Taylor NF, Dodd KJ, Damiano DL. Progressive resistance exercise in physical therapy: a summary of systematic reviews. Phys Ther. 2005 Nov;85(11):1208-23.
- Lee MJ, Kilbreath SL, Singh MF, Zeman B, Davis GM. Effect of progressive resistance training on muscle performance after chronic stroke. Med Sci Sports Exerc. 2010 Jan;42(1):23-34. doi: 10.1249/MSS.0b013e3181b07a31.
- Ashburn A. A physical assessment for stroke patients. Physiotherapy. 1982 Apr;68(4):109-13. No abstract available.
- Teixeira-Salmela LF, Neto MG, Magalhaes LC, Lima RC, Faria CD. Content comparisons of stroke-specific quality of life based upon the international classification of functioning, disability, and health. Qual Life Res. 2009 Aug;18(6):765-73. doi: 10.1007/s11136-009-9488-9. Epub 2009 May 21.
- Carod-Artal FJ, Coral LF, Trizotto DS, Moreira CM. The stroke impact scale 3.0: evaluation of acceptability, reliability, and validity of the Brazilian version. Stroke. 2008 Sep;39(9):2477-84. doi: 10.1161/STROKEAHA.107.513671. Epub 2008 Jul 17.
- Aubuchon JP, Herschel L, Roger J, Dumont L, Murphy S, Slichter SJ, Whitley P, Snyder E, Goodrich RP. Comparison of computerized formulae for determination of platelet recovery and survival. Transfusion. 2005 Jul;45(7):1237-9. doi: 10.1111/j.1537-2995.2005.00187.x. No abstract available.
- Gauthier AP, Verbanck S, Estenne M, Segebarth C, Macklem PT, Paiva M. Three-dimensional reconstruction of the in vivo human diaphragm shape at different lung volumes. J Appl Physiol (1985). 1994 Feb;76(2):495-506. doi: 10.1152/jappl.1994.76.2.495.
- Jung JH, Shim JM, Kwon HY, Kim HR, Kim BI. Effects of Abdominal Stimulation during Inspiratory Muscle Training on Respiratory Function of Chronic Stroke Patients. J Phys Ther Sci. 2014 Jan;26(1):73-6. doi: 10.1589/jpts.26.73. Epub 2014 Feb 6.
- Harms H, Prass K, Meisel C, Klehmet J, Rogge W, Drenckhahn C, Gohler J, Bereswill S, Gobel U, Wernecke KD, Wolf T, Arnold G, Halle E, Volk HD, Dirnagl U, Meisel A. Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One. 2008 May 14;3(5):e2158. doi: 10.1371/journal.pone.0002158.
- Barnard CN. Heart transplantation in the treatment of cardiomyopathy. Recent Adv Stud Cardiac Struct Metab. 1973;2:827-8. No abstract available.
- Kulnik ST. Should we train respiratory muscles after stroke? Neurology. 2015 Aug 18;85(7):560-1. doi: 10.1212/WNL.0000000000001846. Epub 2015 Jul 15. No abstract available.
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CSH-2016-A-006
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.